Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCLA.L Regulatory News (GCLA)

  • There is currently no data for GCLA

Director/PDMR Shareholding

30 Jan 2008 16:31

Grupo Clarin S.A.30 January 2008 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to theshares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating theshares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and17 to 24. (4) An issuer making a notification in respect of a financial instrumentrelating to the shares of the issuer (other than a debenture) should completeboxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer GRUPO CLARIN S.A. .................................... 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made inaccordance with section 324 (as extended by section 328) of the Companies Act1985; or (iii) both (i) and (ii): .................................... 3. Name of person discharging managerial responsibilities/director HECTOR HORACIO MAGNETTO (CHIEF EXECUTIVE OFFICER / DIRECTOR) JOSE ANTONIO ARANDA (DIRECTOR) ALEJANDRO URRICELQUI (DIRECTOR) .................................... 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person N/A .................................... 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest 3 ABOVE .................................... 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares -CLASS B COMMON SHARES OF THE COMPANY, WITH NOMINAL VALUE OF ONE (1) ARGENTINEPESO PER SHARE, AND -CLASS B COMMON SHARES OF THE COMPANY, WITH NOMINAL VALUE OF ONE (1) ARGENTINEPESO PER SHARE IN THE FORM OF GLOBAL DEPOSITARY SHARES .................................... 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them HECTOR HORACIO MAGNETTO Number of shares: (direct and indirect) 60,350,476COMMON SHARES JOSE ANTONIO ARANDA Number of shares: (direct and indirect)20,716,948 COMMON SHARES .................................... 8. State the nature of the transaction ACQUISITION OF CLASS B COMMON SHARES AND CLASS B COMMON SHARES IN THE FORM OFGLOBAL DEPOSITARY SHARES .................................... 9. Number of shares, debentures or financial instruments relating to sharesacquired HECTOR HORACIO MAGNETTO Number of shares: 10,000 GDSs, representing 2 Class B Common Shares each JOSE ANTONIO ARANDA Number of shares: 41,217 GDSs, representing 2 Class B Common Shares each ALEJANDRO URRICELQUI Number of shares: 23,000 Class B Common Shares .................................... 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) HECTOR HORACIO MAGNETTO Percentage: 0.0107% of CLASS B COMMONSHARES JOSE ANTONIO ARANDA Percentage: 0.0443% of CLASS BCOMMON SHARES ALEJANDRO URRICELQUI Percentage: 0.0123% of CLASS BCOMMON SHARES .................................... 11. Number of shares, debentures or financial instruments relating to sharesdisposed N/A .................................... 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) N/A .................................... 13. Price per share or value of transaction HECTOR HORACIO MAGNETTO: 10,000 at US$ 16.10 PER GDS JOSE ANTONIO ARANDA: 10,000 at US$ 17.00 PER GDS 15,000 at US$ 16.15 PER GDS 10,000 at US$ 16.11 PER GDS 6,217 at US$ 16.21 PER GDS ALEJANDRO URRICELQUI: 4,000 at AR$ 27.50 PER SHARE 4,000 at AR$ 27.05 PER SHARE 4,000 at AR$ 27.10 PER SHARE 100 at AR$ 27.25 PER SHARE 5,900 at AR$ 27.25 PER SHARE 5,000 at AR$ 24.00 PER SHARE .................................... 14. Date and place of transaction HECTOR HORACIO MAGNETTO: 10,000 on 24 JANUARY 2008, LONDON JOSE ANTONIO ARANDA: 10,000 on 17 JANUARY 2008, LONDON 15,000 on 22 JANUARY 2008, LONDON 10,000 on 24 JANUARY 2008, LONDON 6,217 on 25 JANUARY 2008, LONDON ALEJANDRO URRICELQUI: 4,000 on 16 JANUARY 2008, BUENOS AIRES 8,000 on 17 JANUARY 2008, BUENOS AIRES 6,000 on 18 JANUARY 2008, BUENOS AIRES 5,000 on 23 JANUARY 2008, BUENOS AIRES.................................... 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) HECTOR HORACIO MAGNETTO : 60,370,476 COMMON SHARES (21.00% OF OUTSTANDING CAPITAL STOCK) JOSE ANTONIO ARANDA: 20,799,382 COMMON SHARES (7.23% OF OUTSTANDING CAPITAL STOCK) ALEJANDRO URRICELQUI: 23,000 COMMON SHARES (0.008% OF OUTSTANDING CAPITAL STOCK) .................................... 16. Date issuer informed of transaction 29 JANUARY 2008 .................................... If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17. Date of grant .................................... 18. Period during which or date on which it can be exercised .................................... 19. Total amount paid (if any) for grant of the option .................................... 20. Description of shares or debentures involved (class and number) .................................... 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise .................................... 22. Total number of shares or debentures over which options held followingnotification .................................... 23. Any additional information N/A .................................... 24. Name of contact and telephone number for queries IN BUENOS AIRES: ALFREDO MARIN/M. JULIA DIAZ ARDAYA GRUPO CLARIN EMAIL: INVESTORS@GRUPOCLARIN.COM IN LONDON: ALEX MONEY/TOM ALLISON TEMPLE BAR ADVISORY TEL: +44 20 7002 1080 EMAIL: CLARIN@TEMPLEBARADVISORY.COM IN NEW YORK: MELANIE CARPENTER/PETER MAJESKI I-ADVIZE CORPORATE COMMUNICATIONS TEL: +1 212 406 3692 EMAIL: CLARIN@I-ADVIZE.COM .................................... Name and signature of duly authorised officer of issuer responsible for makingnotification ALFREDO MARIN, Responsible for Market Relations, Grupo Clarin S.A. .................................... Date of notification 30 JANUARY 2008 .................................... This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th May 20151:00 pmRNSResults for the First Quarter 2015 (1Q15)
7th May 20156:12 pmRNSPayment of Cash Dividends
7th May 20157:54 amRNSNotice of Q1 2015 Results
30th Apr 20157:30 amRNSGCSA Holds Annual Ordinary Shareholders' Meeting
27th Apr 20157:17 amRNSGCLA responds to shareholder information request
24th Apr 20157:39 amRNSBoard Proposes External Auditors for 2015
16th Apr 20157:33 amRNSProposed Change in Allocation of Retained Earnings
30th Mar 20157:00 amRNSMinutes of the Meeting of the Board of Directors
18th Mar 20154:55 pmRNSGrupo Clarin to respond to appeal
18th Mar 20157:00 amRNSAnnual Financial Report
12th Mar 20153:45 pmRNSSecond Price Monitoring Extn
12th Mar 20153:40 pmRNSPrice Monitoring Extension
11th Mar 20155:58 pmRNSBoard Members' Fee Proposal
11th Mar 201512:00 pmRNSResults for Fourth Quarter and Full Year of 2014
5th Mar 20157:00 amRNSBoard Member Leave of Absence
2nd Mar 20157:00 amRNSNotice of Results
23rd Feb 20157:00 amRNSCourt grants injunction
15th Dec 20147:00 amRNSLeave of Absence Request
10th Dec 20147:00 amRNSCourt Grants Injunction
21st Nov 201412:49 pmRNSDividend Declaration
12th Nov 20143:45 pmRNSSecond Price Monitoring Extn
12th Nov 20143:40 pmRNSPrice Monitoring Extension
11th Nov 201412:03 pmRNSResults for Nine Months and Third Quarter of 2014
3rd Nov 20145:12 pmRNSCall and Presentation on 3rd Quarter Results
3rd Nov 20145:07 pmRNSCourt Grants Interim Injunction
10th Oct 20147:43 amRNSAFSCA Rejects Plan
10th Oct 20147:00 amRNSVice Chairman requests leave of absence
7th Oct 20147:21 amRNSBoard of Directors Receives Note from Shareholder
30th Sep 20143:45 pmRNSSecond Price Monitoring Extn
30th Sep 20143:40 pmRNSPrice Monitoring Extension
29th Sep 20144:13 pmRNSLeave of Absence request
25th Sep 20147:15 amRNSGCLA Holds Extraordinary Shareholders' Meeting
18th Sep 20147:00 amRNSGrupo Clarin shareholder summoned to Court
17th Sep 20147:40 amRNSGCLA Responds to Shareholder Information Request
21st Aug 20147:58 amRNSSteps Towards Media Law Compliance
18th Aug 20147:53 amRNSBoard of Directors Considers AFSCA Resolution
15th Aug 20147:00 amRNSAFSCA Rejects Request to Amend Proposal
11th Aug 20141:00 pmRNSResults for First Half and Second Quarter 2014
4th Aug 20143:46 pmRNSSecond Price Monitoring Extn
4th Aug 20143:40 pmRNSPrice Monitoring Extension
1st Aug 20145:30 pmRNSConference call to discuss Q2 2014 Results
15th Jul 20147:03 amRNSGCLA reconvenes Extraordinary Shareholders Meeting
14th Jul 20143:35 pmRNSOffers Relating to Unit 6 and other matters
2nd Jul 20147:14 amRNSGCLA holds Extraordinary Shareholders' Meeting
1st Jul 20147:22 amRNSGrupo Clarin Shareholders' Meeting Adjourned
30th Jun 20147:28 amRNSGCLA Considers Offers Related to Units 4, 5 and 6
25th Jun 20147:17 amRNSResponse to Shareholder Note
23rd Jun 20147:46 amRNSResponse to Shareholder Information Request
19th Jun 20147:39 amRNSPublication of Prospectus
9th Jun 20145:31 pmRNSBoard of Directors Receives Note from Shareholder

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.